Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04125719
Title PVSRIPO in Combination With Nivolumab in Melanoma (PPD1)
Acronym PPD1
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Medical Center Durham North Carolina 27710 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field